Nanoparticles improve biological functions of phthalocyanine photosensitizers used for photodynamic therapy

Current Drug Metabolism

Volumn 13, Issue 8, 2012, Pages 1119-1122

  Jia, Xiao ^a   Jia, Lee ^a,b  

^a FUZHOU UNIVERSITY   (China)

^b NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Drug delivery; Nanocarriers; Nanoparticles; Photodynamic therapy; Phthalocyanine photosensitizers

Indexed keywords

AMPHOPHILE; CARBON NANOTUBE; CETRIMIDE; CHLOROALUMINUM PHTHALOCYANINE; CREMOPHOR; DOXORUBICIN; DRUG CARRIER; FERRIC OXIDE; GOLD 198; GOLD NANOPARTICLE; MACROGOL; MAGNETIC NANOPARTICLE; MAGNETITE NANOPARTICLE; METHACRYLIC ACID DERIVATIVE; NANOCOMPOSITE; NANOHORN; NANOPARTICLE; PHTHALOCYANINE DERIVATIVE; PHTHALOCYANINE ZINC; POLYACRYLAMIDE; POLYCAPROLACTONE; POLYGLYCOLIC ACID; POLYLACTIC ACID; POLYMER; QUANTUM DOT; REACTIVE OXYGEN METABOLITE; SILICON DIOXIDE; SINGLET OXYGEN; TETRASULFOPHTHALOCYANINE ALUMINUM; TITANIUM DIOXIDE;

APOPTOSIS; AQUEOUS SOLUTION; CANCER CELL; CANCER TISSUE; DRUG ACCUMULATION; DRUG ACTIVITY; DRUG BIOAVAILABILITY; DRUG DELIVERY SYSTEM; DRUG RELEASE; DRUG SOLUBILITY; DRUG STABILITY; FLUORESCENCE RESONANCE ENERGY TRANSFER; HELA CELL; HUMAN; HYDROPHOBICITY; NANOEMULSION; PHOTODYNAMIC THERAPY; PHOTOTOXICITY; QUANTUM YIELD; REVIEW; TUMOR GROWTH;

ANIMALS; GOLD; HUMANS; INDOLES; NANOPARTICLES; NEOPLASMS; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; POLYMERS; SILICON DIOXIDE; TITANIUM;

EID: 84868024200     PISSN: 13892002     EISSN: 18755453     Source Type: Journal    
DOI: 10.2174/138920012802850074     Document Type: Review

References (41)

1. Jia, L.; Wong, H.; Cerna, C.; Weitman, S. Effect of nanonization on absorption of 301029: Ex vivo and in vivo pharmacokinetic correlations determined by LC/MS. Pharm. Res., 2002, 19, 1091-6.
2. Jia, L.; Wong, H.; Wang, Y.; Garza, M.; Weitman, S. Carbendazim: Disposition, cellular permeability, metabolite identification and pharmacokinetic comparison with its nanoparticle. J. Pharm. Sci., 2003, 92, 161-72.
3. Jia, L. Nanoparticle formulation Increases oral bioavailability of poorly soluble drugs: experimental evidences, theory, and approaches. Curr. NanoSci., 2005, 1(3), 237-43.
4. Cheng, Y.; C. Samia, A.; Meyers, J. D.; Panagopoulos, I.; Fei, B.; Burda, C. Highly Efficient Drug Delivery with Gold Nanoparticle Vectors for in vivo Photodynamic Therapy of Cancer. J. Am. Chem. Soc., 2008, 130, 10643-7.
5. Cheng, Y.; Meyers, J. D.; Broome, A.-M.; Kenney, M. E.; Basilion, J. P.; Burda, C. Deep Penetration of a PDT Drug into Tumors by Noncovalent Drug-Gold Nanoparticle Conjugates. J. Am. Chem. Soc., 2011, 133, 2583-91.
6. Cheng, Y.; Samia, A. C.; Li, J.; Kenney, M. E.; Resnick, A.; Burda, C. Delivery and Efficacy of a Cancer Drug as a Function of the Bond to the Gold Nanoparticle Surface. Langmuir, 2009, 26, 2248-55.
7. Ghosh, P.; Han, G.; De, M.; Kim, C. K.; Rotello, V. M. Gold nanoparticles in delivery applications. Adv. Drug Delivery Rev., 2008, 60, 1307-15.
8. Hone, D. C.; Walker, P. I.; Evans-Gowing, R.; FitzGerald, S.; Beeby, A.; Chambrier, I.; Cook, M. J.; Russell, D. A. Generation of Cytotoxic Singlet Oxygen via Phthalocyanine-Stabilized Gold Nanoparticles: A Potential Delivery Vehicle for Photodynamic Therapy. Langmuir, 2002, 18, 2985-7.
9. Camerin, M.; Magaraggia, M.; Soncin, M.; Jori, G.; Moreno, M.; Chambrier, I.; Cook, M. J.; Russell, D. A. The in vivo efficacy of phthalocyanine - nanoparticle conjugates for the photodynamic therapy of amelanotic melanoma. Eur. J. Cancer, 2010, 46, 1910-8.
10. Manthe, R. L.; Foy, S. P.; Krishnamurthy, N.; Sharma, B.; Labhasetwar, V. Tumor Ablation and Nanotechnology. Mol. Pharmaceut., 2010, 7, 1880-98.
11. Wieder, M. E.; Hone, D. C.; Cook, M. J.; Handsley, M. M.; Gavrilovic, J.; Russell, D. A. Intracellular photodynamic therapy with photosensitizer- nanoparticle conjugates: cancer therapy using a 'Trojan horse'. Photoch Photobio Sci., 2006, 5, 727-34.
12. Li, L.; Chen, J.Y.; Wu, X.; Wang, P. N.; Peng, Q. Plasmonic Gold Nanorods Can Carry Sulfonated Aluminum Phthalocyanine To Improve Photodynamic Detection and Therapy of Cancers. J. Phys. Chem. B, 2010, 114, 17194-200.
13. Jang, B.; Park, J.-Y.; Tung, C.-H.; Kim, I.-H.; Choi, Y. Gold Nanorod - Photosensitizer Complex for Near-Infrared Fluorescence Imaging and Photodynamic/Photothermal Therapy in vivo. ACS Nano., 2011, 5, 1086-94.
14. Samia, A. C. S.; Chen, X.; Burda, C. Semiconductor Quantum Dots for Photodynamic Therapy. J. Am. Chem. Soc., 2003, 125, 15736-7.
15. Ma, J.; Chen, J.Y.; Idowu, M.; Nyokong, T. Generation of Singlet Oxygen via the Composites of Water-Soluble Thiol-Capped CdTe Quantum DotsSulfonated Aluminum Phthalocyanines. J. Phys. Chem. B, 2008, 112, 4465-9.
16. 4 hybrid microspheres. Appl. Surf. Sci., 2011, 257, 5000-6.
17. Primo, F. L.; Rodrigues, M. M. A.; Simioni, A. R.; Bentley, M. V. L. B.; Morais, P. C.; Tedesco, A. C. in vitro studies of cutaneous retention of magnetic nanoemulsion loaded with zinc phthalocyanine for synergic use in skin cancer treatment. J. Magn. Magn. Mater., 2008, 320, 211-4.
18. Zhao, B.; Yin, J. J.; Bilski, P. J.; Chignell, C. F.; Roberts, J. E.; He, Y.Y. Enhanced photodynamic efficacy towards melanoma cells by encapsulation of Pc4 in silica nanoparticles. Toxicol. Appl. Pharmacol., 2009, 241, 163-72.
19. Kim, H. J.; Shin, K. J.; Han, M. K.; An, K.; Lee, J. K.; Honma, I.; Kim, H. One-pot synthesis of multifunctional mesoporous silica nanoparticle incorporated with zinc(II) phthalocyanine and iron oxide. Scr. Mater., 2009, 61, 1137-40.
20. Rodrigues, M. M. A.; Simioni, A. R.; Primo, F. L.; Siqueira-Moura, M. P.; Morais, P. C.; Tedesco, A. C. Preparation, characterization and in vitro cytotoxicity of BSA-based nanospheres containing nanosized magnetic particles and/or photosensitizer. J. Magn. Magn. Mater., 2009, 321, 1600-3.
21. Stuchinskaya, T.; Moreno, M.; Cook, M. J.; Edwards, D. R.; Russell, D. A. Targeted photodynamic therapy of breast cancer cells using antibody- phthalocyanine-gold nanoparticle conjugates. Photochem. Photobiol. Sci., 2011, 10, 822-31.
22. Ricci-Júnior, E.; Marchetti, J. M. Preparation, characterization, photocytotoxicity assay of PLGA nanoparticles containing zinc (II) phthalocyanine for photodynamic therapy use. J. Microencapsulation, 2006, 23, 523-38.
23. Ricci-Júnior, E.; Marchetti, J. M. Zinc(II) phthalocyanine loaded PLGA nanoparticles for photodynamic therapy use. Int. J. Pharm., 2006, 310, 187-95.
24. Toyokazu, S. M., O.; Yukio, N. Photochemical and Photobiological Studies of Zinc Phthalocyanine Incorporated into PEGylated Nanogels for Photodynamic Therapy. J. Photopolym. Sci. Technol, 2009, 22, 547-50.
25. Fu, J.; Li, X.-y.; Ng, D. K. P.; Wu, C. Encapsulation of Phthalocyanines in Biodegradable Poly(sebacic anhydride) Nanoparticles. Langmuir, 2002, 18, 3843-7.
26. Kuruppuarachchi, M.; Savoie, H.; Lowry, A.; Alonso, C.; Boyle, R. W. Polyacrylamide Nanoparticles as a Delivery System in Photodynamic Therapy. Mol Pharmaceut, 2001, 8, 920-31.
27. Leroux, J. C.; Roux, E.; Le Garrec, D.; Hong, K.; Drummond, D. C. N-isopropylacrylamide copolymers for the preparation of pH-sensitive liposomes and polymeric micelles. J. Control. Release, 2001, 72, 71-84.
28. Dufresne, M. H.; Garrec, D. L.; Sant, V.; Leroux, J. C.; Ranger, M. Preparation and characterization of water-soluble pH-sensitive nanocarriers for drug delivery. Int. J. Pharm., 2004, 277, 81-90.
29. Da Volta Soares, M.; Oliveira, M.; dos Santos, E.; Ricci-Júnior, E. Nanostructured delivery system for zinc phthalocyanine: preparation, characterization, and phototoxicity study against human lung adenocarcinoma A549 cells. Int. J. Nanomed., 2011, 6, 227-38.
30. Allémann, E.; Brasseur, N.; Benrezzak, O.; Rousseau, J.; Kudrevich, S. V.; Boyle, R. W.; Leroux, J.-C; Gurny, R.; Van Lier, J. E. PEG-coated Poly(lactic acid) Nanoparticles for the Delivery of Hexadecafluoro Zinc Phthalocyanine to EMT-6 Mouse Mammary Tumours. J. Pharm. Pharmacol, 1995, 47, 382-7.
31. Allémann, E.; Rousseau, J.; Brasseur, N.; Kudrevich, S. V.; Lewis, K.; van Lier, J. E. Photodynamic therapy of tumours with hexadecafluoro zinc phthalocyanine formulated in PEG-coated poly(lactic acid) nanoparticles. Int. J. Cancer, 1996, 66, 821-4.
32. Fadel, M.; Kassab, K.; Abdel Fadeel, D. Zinc phthalocyanineloaded PLGA biodegradable nanoparticles for photodynamic therapy in tumor-bearing mice. Lasers Med. Sci., 2010, 25, 283-92.
33. Bianco, A.; Kostarelos, K.; Partidos, C. D.; Prato, M. Biomedical applications of functionalised carbon nanotubes. Chem. Commun., 2005, 41, 571-7.
34. Bianco, A.; Kostarelos, K.; Prato, M. Applications of carbon nanotubes in drug delivery. Curr. Opin. Chem. Biol, 2005, 9, 674-9.
35. Klumpp, C.; Kostarelos, K.; Prato, M.; Bianco, A. Functionalized carbon nanotubes as emerging nanovectors for the delivery of therapeutics. Biochim. Biophys. Acta, Biomembr., 2006, 1758, 404-12.
36. Zhang, M.; Murakami, T.; Ajima, K.; Tsuchida, K.; Sandanayaka, A. S. D.; Ito, O.; Iijima, S.; Yudasaka, M. Fabrication of ZnPc/protein nanohorns for double photodynamic and hyperthermic cancer phototherapy. Proc. Nat. Acad. Sci. U.S.A., 2008, 105, 14773-8.
37. Xu, Z.; Li, H.; Sun, H.; Zhang, Q.; Li, K. Carbon Nanotubes with Phthalocyanine-Decorated Surface Produced by NH3-Assisted Microwave Reaction and Their Catalytic Performance in Li/SOCl2 Battery. Chin. J. Chem., 2010, 28, 2059-66.
38. Ye, J. S.; Wen, Y.; De Zhang, W.; Cui, H. F.; Xu, G. Q.; Sheu, F. S. Electrochemical Biosensing Platforms Using Phthalocyanine-Functionalized Carbon Nanotube Electrode. Electroanal, 2005, 17, 89-96.
39. Mamuru, S. A.; Ozoemena, K. I. Heterogeneous Electron Transfer and Oxygen Reduction Reaction at Nanostructured Iron(II) Phthalocyanine and Its MWCNTs Nanocomposites. Electroanal, 2010, 22, 985-94.
40. Kharisov, B. I.; Kharissova, O. V.; Leija Gutierrez, H.; Ortiz Méndez, U. Recent Advances on the Soluble Carbon Nanotubes. Ind. Eng. Chem. Res., 2008, 48, 572-90.
41. 2 for photodynamic therapy applications. Nanomed-Nanotechnol, 2010, 6, 777-85.